MNCs tell UK govt of animal activism concerns

4 April 2001

Five multinational pharmaceutical manufacturers have written to UK HomeSecretary Jack Straw about their concerns at the escalating problem of violence from animal rights activists in the UK, according to Trevor Jones, director general of the Association of the British Pharmaceutical Industry.

Speaking at the launch of the ABPI's Annual Review (see also page 11), Prof Jones said he had received letters from the research directors of five leading research-based multinationals, although he declined to identify the companies. He added that a number of Japanese firms which were considering establishing research facilities in the UK had also noted their concerns.

"It would be a disaster for the country if companies decided that vital research into new medicines would have to be conducted abroad because of the unacceptable actions of a few extremists," said Prof Jones, adding that he believed the campaign was the work of no more than 20 activists, organized into six to eight cells.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight